Registration - Consultant Lobbyist
Innovative Medicines Canada / Greg D'Avignon, Consultant Lobbyist
Registration Information
Lobbyist name: Greg D'Avignon, Consultant Lobbyist
Initial registration start date: 2025-09-11
Registration status: Active
Projected end date: 2026-08-31
Registration number: 1251-6178
Version 1 of 1 (2025-09-11 to present)
Version 1 of 1 (2025-09-11 to present)
Lobbying Information
Details Regarding the Identified Subject Matter |
||||||||||||||||
| Will the consultant lobbyist be arranging meetings between a public office holder and the client for the purpose of attempting to influence any of the matters listed: | Yes | |||||||||||||||
|
||||||||||||||||
BC Ministries/Provincial Entities
- Health
- Indigenous Relations and Reconciliation
- Jobs and Economic Growth
- Member(s) of the BC Legislative Assembly
- Office of the Premier
- Parliamentary Secretary for Rural Health
- Provincial Health Services Authority
Contingency Information
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the outcome of this lobbying activity.
- Payment to the consultant lobbyist by the client, in whole or in part, is not contingent on the success in arranging a meeting with public office holders on behalf of the client.
Client Details
Client Contact Information
Innovative Medicines Canada
Address:
55 Metcalfe Street, Suite 1220
Ottawa, ON K1P 6L5
Canada
Website:
https://innovativemedicines.ca/
Description of Business Activities
Innovative Medicines Canada partners to champion policies that drive the discovery, investment in development and delivery of transformative medicines and vaccines to all Canadians while supporting patients to live longer and healthier lives.
Contributors to the Lobbying Activity
No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.
Government Funding in the Last 12 Months
No government funding was received within the preceding 12 months based on the submission date requirements for this registration.Other Entities (working together for the purposes of lobbying) Information
Innovative Medicines Canada is not working together with any other entity for the purpose of lobbying.
Affiliates with a Direct Interest in the Outcome
Innovative Medicines Canada does not have any affiliates that could have a direct interest in the outcome of the lobbying activities
Other Persons or Organizations with Direct Interests
The activities of Innovative Medicines Canada are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.
Lobbyist Details
Greg D'Avignon | Has not held any “former public office holder” positions in BC, as defined in the Lobbyists Transparency Act
10103 97A Avenue NW
Edmonton, AB T5K 2T3
Canada
Relevant Codes of Conduct
The consultant lobbyist does not have in place an undertaking to comply with any relevant codes of conduct.
Political, Sponsorship and Recall Contributions
| Consultant has lobbied, or plans to lobby a member of the Legislative Assembly, including a Minister or Premier, on behalf of this client, on or after 2024-09-21: | Yes | |||||||||||||||
|
||||||||||||||||
Gifts or Benefits Provided to Public Officer Holders
No gifts or benefits were provided to public office holdersIndividuals Hired or Subcontracted to Lobbying on behalf of the Client
- Brent Korte
Consultant Lobbyist Firm and Address
Firm: CSG Canadian Strategy Group LP
10103 97A Avenue NW
Edmonton, AB T5K 2T3
Canada
- Date Modified: